Pa. investing in Lehigh Valley biotech companies to manufacture COVID-19 oral vaccine

Written by on December 4, 2020

Pa. investing in Lehigh Valley biotech companies to manufacture COVID-19 oral vaccine

By Tyler Pratt

December 4, 2020

VadimVasenin/Depositphotos

The state of Pennsylvania is investing hundreds of thousands of dollars in Lehigh Valley pharmaceutical companies to create COVID-19 vaccines. And as WLVR’s Tyler Pratt reports, it could bring nearly 100 new jobs to the area.

Listen to the story.

$291,000 dollars, that’s how much the state’s giving to Bethlehem’s U.S. Specialty Formulations, which has partnered with another Valley biotech company, VaxForm.

Dennis Davin heads up the PA Department of Economic and Community Development. 

“This is a major investment in the Lehigh Valley and state as a whole knowing there will be a global demand for COVID-19 vaccines.”

The companies are kicking in $5 million of their own to build a large facility in Allentown and hire about 97 employees to manufacture two new vaccines. Garry Morefield runs VaxForm. 

“Our initial target for March of next year is to be able to produce 300k doses per month.”

The vaccines will be oral – in liquid and pill form – and don’t need extreme cold storage, like the new Pfizer injection expected later this month. The oral vaccines can be delivered to rural areas and third world countries more efficiently. 

Sign up for our WLVR weekly newsletter to stay up to date with the latest news from the Lehigh Valley and across Pennsylvania.


News

Current track

Title

Artist

Background